A) Geodon B) Zyprexa C) Risperdal D) Prolixin
A) Zyprexa B) Abilify C) Clozaril D) Invega
A) Abilify B) Invega C) Zyprexa D) Seroquel
A) Abilify B) Zyprexa C) Seroquel D) Risperdal
A) Abilify B) Risperdal C) Geodon D) Seroquel
A) Clozapine B) Ziprasidone C) Olanzapine D) Quetiapine
A) Aripriprazole B) Risperidone C) Paliperidone D) Ziprasidone
A) Seroquel B) Geodon C) Risperdal D) Clozaril
A) Aripiprazole B) Clozapine C) Paliperidone D) Ziprasidone
A) Olazapine B) Quetiapine C) Risperdone D) Paliperidone
A) Risperidone and Paliperidone B) Clozapine and Risperadone C) Aripiprazole and Paliperidone D) Clozapine and Aripiprazole
A) 1 B) 4-5 C) 1-3 D) 2-5
A) 6 B) 18 C) 12 D) 24
A) FALSE B) TRUE
A) Prevent relapse into another psychotic episode B) Foster patients' medication compliance C) Minimize side effects of medication D) Develop more adaptive coping skills
A) six months after discontinuation of medication B) one year after discontinuation of medication C) several weeks after discontinuation of medication D) directly after discontinuation of medication
A) Thorazine B) Symmetrel C) Artane D) Clozaril
A) increased effectiveness for positive, negative, and disorganized symptoms B) tardive dyskinesia more common C) enhanced efficacy in treatment-resistant patients D) weight gain more common
A) Risperidone B) Haloperiodol C) Clozapine D) Prochlorperazine
A) Anxiolitics B) Anticonvulsants C) Alcohol D) Stimulants
A) Beta blockers B) Merperidine C) Alcohol D) Halperiodol
A) Anticonvulsants B) Antacids C) Nicotine D) Beta blockers
A) SSRIs B) Alcohol C) Tricyclic antidepressants D) Beta blockers
A) FALSE B) TRUE
A) Alcohol use B) Male gender C) Drug holidays D) Tobacco use
A) FALSE B) TRUE
A) All antipsychotic drugs but Clozapine present a significant risk for the development of tardive dyskinesia. B) Classic antipsychotic medications present less risk for the development of tardive dyskinesia than atypical antipsychotic medications. C) The more frequent the dose of the antipsychotic medication, the greater the risk for the development of tardive dyskinesia. D) High potency antipsychotic drugs present greater risk for the development of tardive dyskinesia.
A) Ataxia B) Akinesia C) Acute dystonia D) Akathesia
A) Agranulocytosis B) Neuroleptic Malignant Syndrome C) Postural hypotension D) Gynecomastia
A) TRUE B) FALSE
A) FALSE B) TRUE
A) antagonize the normal dopamine-mediated inhibition of prolactin release. B) agonize the normal dopamine-mediated inhibition of prolactin release. C) block D2 receptors in the pituitary gland and decrease prolactin secretion. D) block D2 receptors in the pituitary gland and inhibit prolactin secretion.
A) hungry hungry hippos B) receptor binding and DA turnover C) neuroendocrine changes D) molecular structure
A) Thioxanthenenes B) Butyrophenones C) Phenothiazines D) Sleepykoaladones
A) Weak; high; lower B) Potent; low; higher C) Weak; high; higher D) Potent; low; lower
A) Delusions B) Anhedonia C) Hallucinations D) Formal thought disorder
A) Autoimmune diseases B) Neurological disorders C) Metabolic disorders D) Endocrine disorders E) All of the above
A) Stimulants B) Hallucinogens C) All of the above D) Alcohol E) Opioids
A) TRUE B) FALSE
A) positive symptoms of Schizophrenia. B) All of the above. C) disorganized symptoms of Schizophrenia. D) negative symptoms of Schizophrenia.
A) blocking post-synaptic dopamine receptors and/or inhibiting dopamine reuptake. B) blocking post-synaptic dopamine receptors and/or inhibiting dopamine release. C) blocking pre-synaptic dopamine receptors and/or inhibiting dopamine reuptake. D) blocking pre-synaptic dopamine receptors and/or inhibiting dopamine release.
A) the drug increases the normal dopamine-mediated activity in the striatum, which then reduces the cholinergic response that is normally inhibited by dopamine. B) the drug reduces the normal dopamine-mediated activity in the striatum, which then enhances the cholinergic response that is normally inhibited by dopamine. C) the drug reduces the normal dopamine-mediated activity in the striatum, which then reduces the cholinergic response that is normally inhibited by dopamine. D) the drug increases the normal dopamine-mediated activity in the striatum, which then enhances the cholinergic response that is normally inhibited by dopamine.
A) increased tap dancing B) increased release of dopamine C) increased rates of synthesis D) increased rates of firing
A) aliphatics B) thioxanthenes C) piperazines D) piperideines
A) galactorrhea B) menstrual irregularity C) all of the above D) genecomastia
A) Benadryl (diphenhydramine) B) Cogentin (benztropine) C) Symmetrel (amantadine) D) Artane (trihexphenidyl) E) Inapsine (droperiodol)
A) TRUE B) FALSE
A) actual impact at the biological level B) polypharmacy C) comparative lack of EPS D) superior impact on positive symptoms
A) Abilify B) Invega C) Clozaril D) Haldol
A) Risperdal B) Geodon C) Seroquel D) Clorazil |